Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11676 - 11700 of 12740 in total
Experimental
Matched Iupac: … (2S)-2-amino-6-(dimethylamino)hexanoic acid …
Experimental
Matched Iupac: … [hydroxy(propan-2-yl)carbamoyl]formic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-(sulfooxy)propanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-(phosphonosulfanyl)propanoic acid …
Experimental
Matched Iupac: … (2S,3R)-2-amino-3-hydroxybutanedioic acid …
Experimental
Matched Iupac: … (2R,3R)-2-amino-3-hydroxybutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-6-(carboxyamino)hexanoic acid …
Experimental
Matched Iupac: … {[2-(4-iodophenyl)acetamido]methyl}phosphinic acid …
Experimental
Matched Iupac: … (2R)-2-hydroxy-3-(phosphonooxy)propanoic acid …
Experimental
Matched Iupac: … tert-butyl (2S)-2-amino-4-carbamoylbutanoate …
C31G is a potent broad spectrum antimicrobial agent, effective against gram positive and gram negative bacteria, yeast and fungi.C31G, vaginal gel is developed by Biosyn Inc. and has commenced enrollment in a phase III pivotal clinical trial for the reduction of sexual transmission of human immunodeficiency virus (HIV).
Investigational
Matched Iupac: … N,N-dimethyldodecanamine oxide 2-(dodecyldimethylazaniumyl)acetate …
Chlorotoxin I-131 is investigated in clinical trials for treating brain cancer. Chlorotoxin I-131 binds to and reduces the activity of a matrix metalloproteinase (MMP) that regulates functioning of the chloride channels on cell membranes. Chlorotoxin is a small 36-amino-acid peptide that selectively binds to glioma cells but not normal brain...
Investigational
Matched Iupac: … {2-[4-(1,2-diphenylbutyl)phenoxy]ethyl}dimethylamine …
Experimental
Matched Iupac: … (2S)-2-[(ethoxycarbonyl)amino]-4-methylpentanoic acid …
Experimental
Matched Iupac: … [(1R)-1-amino-2-phenylethyl]boronic acid …
Experimental
Matched Iupac: … 1,1,1-trifluoro-3-(octylsulfanyl)propan-2-one …
Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI. It has been used to research obesity and energy balance, and exerts some local analgesia effects.
Experimental
Matched Iupac: … [3-(2-methoxyphenoxy)-3-phenylpropyl](methyl)amine …
Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.
Investigational
Matched Iupac: … 4-{2-[(4-methylphenyl)sulfanyl]phenyl}piperidine …
Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … 1,3-bis(butanoyloxy)propan-2-yl butanoate …
Experimental
Matched Iupac: … N-(4-aminobenzenesulfonyl)-3-methylbut-2-enamide …
Experimental
Matched Iupac: … 2,2,2-trichloroethane-1,1-diol; 2-acetamidoacetic acid …
Ampreloxetine is under investigation in clinical trial NCT03750552 (Clinical Effect of TD-9855 for Treating snOH in Subjects With Primary Autonomic Failure).
Investigational
Matched Iupac: … 4-{2-[(2,4,6-trifluorophenoxy)methyl]phenyl}piperidine …
GED-0507-34-Levo is under investigation in clinical trial NCT02808390 (Efficacy and Safety Study of Ged-0507-34-levo for Treatment of UC).
Investigational
Matched Iupac: … (2S)-3-(4-aminophenyl)-2-methoxypropanoic acid …
Experimental
Matched Iupac: … {[(3R)-4-[(2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]-1,3-dihydroxybutan-2-yl]oxy}-lambda4 …
Experimental
Matched Iupac: … (2S)-N-[(1S)-1-carbamoyl-2-{4-[(5S)-1,1,3-trioxo-1lambda6,2-thiazolidin-5-yl]phenyl}ethyl]-2-acetamido …
Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.
Investigational
Matched Iupac: … N-[(2R)-butan-2-yl]-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine …
Displaying drugs 11676 - 11700 of 12740 in total